Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -111.49% | -11.41% | -46.04% | 80.09% | -148.36% |
| Total Depreciation and Amortization | -3.60% | 4.47% | 13.85% | -12.79% | 65.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.19% | 21.44% | 147.58% | -95.24% | 276.26% |
| Change in Net Operating Assets | 55.81% | 447.49% | 54.21% | 7.03% | -11,130.00% |
| Cash from Operations | -23.17% | 28.30% | -7.19% | -9.47% | 3.24% |
| Capital Expenditure | -40.86% | -200.86% | -13.68% | -43.46% | -145.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -40.86% | -200.86% | -13.68% | -46.19% | -141.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -198.33% | -5.26% | -16.33% | -19.51% | 4.65% |
| Issuance of Common Stock | -- | -- | -100.00% | 143.08% | 66,505.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 54.49% | -472.19% |
| Cash from Financing | -110.00% | -5.26% | -100.40% | 163.52% | 4,349.80% |
| Foreign Exchange rate Adjustments | 85.71% | -- | -- | -- | 85.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.21% | 14.31% | -130.11% | 324.67% | 189.48% |